Literature DB >> 7620032

Cryptococcal empyema: case report and review.

V E Mulanovich1, W E Dismukes, N Markowitz.   

Abstract

A 28-year-old male infected with the human immunodeficiency virus (HIV) developed a pleural empyema caused by Cryptococcus neoformans. He responded well to chest-tube drainage and antifungal therapy; he received fluconazole as maintenance therapy for 1 year and has not relapsed. We reviewed the English-language literature on cryptococcal pleural effusions in patients with and without AIDS. Only three other cases of empyema, one of them in an HIV-infected patient, have been reported. A pleural-fluid cryptococcal antigen test was diagnostic in our case and should be included in the diagnostic evaluation of unexplained pleural empyema/effusion in immunocompromised patients.

Entities:  

Mesh:

Year:  1995        PMID: 7620032     DOI: 10.1093/clinids/20.5.1396

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Uncommon mycosis in a patient with diabetes.

Authors:  Kuruswamy Thurai Prasad; Inderpaul Singh Sehgal; M R Shivaprakash; Sahajal Dhooria
Journal:  BMJ Case Rep       Date:  2016-02-25

Review 2.  Cryptococcus neoformans empyema in a patient receiving ibrutinib for diffuse large B-cell lymphoma and a review of the literature.

Authors:  Christopher David Swan; Thomas Gottlieb
Journal:  BMJ Case Rep       Date:  2018-07-18

Review 3.  Cryptococcal pleuritis with pleural effusion as the only clinical presentation in a patient with hepatic cirrhosis: A case report and literature review.

Authors:  Jie Wang; Jin-Jing Hong; Piao-Piao Zhang; Mei-Fang Yang; Qing Yang; Ting-Ting Qu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  Disseminated Cryptococcal Disease in A Patient With Chronic Chylothorax and a Pleurovenous Catheter, a Case Report With Autopsy Findings.

Authors:  William Mundo; Amber Berning; Yiannis Koullias; Daniel B Chastain; Neil Stone; Carlos Franco-Paredes; Andrés F Henao-Martínez; Lilian Vargas Barahona
Journal:  Open Forum Infect Dis       Date:  2021-05-19       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.